Elevance Health's Return On Capital Employed Insights
Portfolio Pulse from Benzinga Insights
Elevance Health (NYSE:ELV) reported a loss in earnings of $1.86 billion in Q2, but sales increased by 3.53% to $43.38 billion. The company posted a Return on Capital Employed (ROCE) of 0.05%, indicating effective capital allocation. Elevance Health's Q2 earnings per share were $9.04, beating analyst predictions of $8.8.
July 20, 2023 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Elevance Health reported a Q2 loss but showed increased sales and effective capital allocation. The company's EPS beat analyst predictions.
Despite the reported loss, Elevance Health showed positive signs in Q2 with increased sales and effective capital allocation. The company's EPS also beat analyst predictions, which could potentially boost investor confidence. However, the overall impact on the stock price is uncertain due to the mixed results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100